Journal article icon

Journal article

Cost-effectiveness of dopamine agonists and monoamine oxidase B inhibitors in Parkinson’s

Abstract:

Background The PD MED study reported small but persistent benefits in patient-rated mobility scores and quality of life from initiating therapy with levodopa compared with levodopa-sparing therapies in early Parkinson's disease (PD). Objectives The objective was to estimate the cost-effectiveness of levodopa-sparing therapy (dopamine agonists or monoamine oxidase type B inhibitors compared with levodopa alone. Methods PD MED is a pragmatic, open-label randomized, controlled trial in which p...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1002/mds.28623

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Role:
Author
ORCID:
0000-0003-0239-7278
More from this funder
Name:
National Institute for Health Research Health Technology Assessment Programme
Publisher:
Wiley
Journal:
Movement Disorders More from this journal
Volume:
36
Issue:
9
Pages:
2136-2143
Publication date:
2021-05-07
Acceptance date:
2021-04-05
DOI:
EISSN:
1531-8257
ISSN:
0885-3185
Language:
English
Keywords:
Pubs id:
1172642
Local pid:
pubs:1172642
Deposit date:
2021-04-20

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP